Bispecifics Could Be A Threat To CAR-Ts, But Efficacy May Trump Convenience

 
• By Mandy Jackson
  
3d illustration of T cells or cancer cells,3d rendering.
CAR-T competition? It may come from bispecifics that engage T-cells. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip